Vaxcyte, Inc (PCVX) insider trading
Every open-market stock purchase and sale by Vaxcyte, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Andrew Guggenhime (CFO) and 3 others sold $3.7M in the last 90 days.
- Last insider buy: TPG Group Holdings (SBS) Advisors Inc. (10% owner), $15M, 6 years ago.
- Congress: Gilbert Cisneros bought $1K to $15K, 5 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $9M (20 sales). Last close $59.47 on Sep 11, 2026.
Recent PCVX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | Jim Wassil (COO) | Sold | $79.4K |
| Sep 8, 2026 | Grant Pickering (CEO) | Sold (not open market) | $1M |
| Sep 8, 2026 | Harpreet S. Dhaliwal (CTO) | Sold (not open market) | $462K |
| Sep 8, 2026 | Andrew Guggenhime (CFO) | Sold (not open market) | $432K |
| Sep 8, 2026 | Jim Wassil (COO) | Sold (not open market) | $330K |
| Sep 8, 2026 | Elvia Cowan (C-suite exec) | Sold (not open market) | $80.1K |
| Sep 4, 2026 | Jim Wassil (COO) | Sold | $84.5K |
| Sep 4, 2026 | Luis Jodar (C-suite exec) | Bought (not open market) | — |
| Sep 4, 2026 | Luis Jodar (C-suite exec) | Bought (not open market) | — |
| Sep 2, 2026 | Grant Pickering (CEO) | Sold (not open market) | $211K |
| Sep 2, 2026 | Andrew Guggenhime (CFO) | Sold (not open market) | $88.2K |
| Sep 2, 2026 | Jim Wassil (COO) | Sold (not open market) | $88.2K |
| Sep 2, 2026 | Harpreet S. Dhaliwal (CTO) | Sold (not open market) | $40.6K |
| Sep 2, 2026 | Elvia Cowan (C-suite exec) | Sold (not open market) | $20.1K |
| Sep 1, 2026 | Jim Wassil (COO) | Sold | $93.6K |
| Sep 1, 2026 | Jim Wassil (COO) | Sold | $56.3K |
| Sep 1, 2026 | Jim Wassil (COO) | Sold | $43.8K |
| Sep 1, 2026 | Jim Wassil (COO) | Sold | $18.6K |
| Sep 1, 2026 | Jim Wassil (COO) | Bought (not open market) | — |
| Aug 31, 2026 | Grant Pickering (CEO) | Sold (not open market) | $174K |
| Aug 31, 2026 | Jim Wassil (COO) | Sold (not open market) | $77.3K |
| Aug 31, 2026 | Andrew Guggenhime (CFO) | Sold (not open market) | $77.3K |
| Aug 31, 2026 | Harpreet S. Dhaliwal (CTO) | Sold (not open market) | $21.9K |
| Aug 31, 2026 | Elvia Cowan (C-suite exec) | Sold (not open market) | $14.8K |
| Aug 5, 2026 | Harpreet S. Dhaliwal (CTO) | Sold | $935K |
Who's trading PCVX
- Jim Wassil, COO: sold $1.4M (18 sales), last Sep 9, 2026
- Grant Pickering, CEO: sold $3.6M (18 sales), last Sep 8, 2026
- Elvia Cowan, VP: sold $989K (6 sales), last Sep 8, 2026
- Harpreet S. Dhaliwal, CTO: sold $1.4M (2 sales), last Sep 8, 2026
- Andrew Guggenhime, CFO: sold $1.6M (5 sales), last Sep 8, 2026
- Luis Jodar, C-suite exec: other filings, last Sep 4, 2026
- John Markels, Director: other filings, last Jul 16, 2026
- Moncef Slaoui, Director: other filings, last Jun 22, 2026
- Olivier Brandicourt, Director: other filings, last Jun 15, 2026
- Anne S Drapeau, Director: other filings, last Jun 15, 2026
- John Furey, Director: other filings, last Jun 15, 2026
- Halley E Gilbert, Director: other filings, last Jun 15, 2026
- Jacks Lee, Director: other filings, last Jun 15, 2026
- Teri Loxam, Director: other filings, last Jun 15, 2026
- Heath Lukatch, Director: other filings, last Jun 15, 2026
Get free alerts when an insider at Vaxcyte, Inc files a new trade →